The Cure Hepatitis C Act of 2026 aims to eliminate hepatitis C in the United States by coordinating federal efforts, improving access to treatment.
The Cure Hepatitis C Act of 2026 mandates the Secretary of Health and Human Services to establish the Hepatitis C Elimination Program, coordinating federal efforts to eliminate hepatitis C. The Act requires the Secretary to issue a national strategy and implementation plan, detailing priority populations, goals, objectives, and strategies for improving hepatitis C prevention, detection, and treatment. It also mandates the creation of a subscription program for hepatitis C treatments, ensuring no cost-sharing for direct acting antivirals in Medicare Part D for plan years 2028 through 2032.
Included in complete analysis
- Overview
- Core Provisions
- Implementation
- Impact
- Legal Framework
- Critical Issues
See what it does, who it affects, and the critical issues in plain language. Free, 30 seconds.